CATX

Conviction 8HealthcareScan · Thu, Sep 24, 2026

Perspective Therapeutics, Inc. (CATX) closed at $2.49 (-4.96%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 24, -55.9% from its 52-week high, -10.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

CATX$2.49-4.96%

ResistanceSupportVol 14Insider sell

Vol MA14 2.71M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Perspective Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.perspectivetherapeutics.com ↗

Price2.49

Change-4.96%

Gap-1.53%

Rel volume0.99×

Avg volume2.15M

Avg $ vol6.21M

SMA 202.94

SMA 503.01

SMA 2003.61

Price vs 50-17.33%

Price vs 200-30.96%

MA stackbearish

50/200 cross—

Supertrenddown · 3.13

RSI (14)33

MACD hist-0.03

MACD cross—

Stoch %K / %D7 / 27

ADX (14)15

+DI / −DI15 / 30

RSI divergence—

MACD divergence—

ATR %7.93%

ADR %5.94%

52w high5.65

52w low2.05

From 52w high-55.93%

Above 52w low+21.46%

New 52w highNo

SqueezeOff

Bollinger width26.38%

%B-0.08

Donchian pos6.25%

Donchian high3.24

Donchian low2.44

AVWAP (52w high)4.00

vs AVWAP high-37.68%

AVWAP (52w low)3.80

vs AVWAP low-34.48%

OBV trendDown

Chaikin MF (20)0.14

Today vs 20d0.99×

Avg vol (14d)2.71M

Avg vol (20d)2.15M

Avg $ vol (20d)6.21M

Market cap284.24M

RS Rating24 / 99

RS 3m (vs SPY)-21.49%

RS 6m (vs SPY)-61.73%

RS line new highNo

Trend template2/8

Technical rank9.3

1 week-13.54%

1 month-24.32%

3 months-17.00%

6 months-44.91%

1 year-21.45%

YTD-10.75%

P/E-2.76

P/B0.88

P/S47.99

P/FCF-2.98

EPS-1.40

Div yield—

ROE-31.84%

ROA-26.30%

Debt/Eq0.00

Current6.61

EV/EBITDA-2.15

Gross margin24.21%

Net margin—

Rev growth24.41%

EPS growth-30.07%

Price target12.78

Target upside413.25%

Analyst ratingBuy

Institutional79.47%

Ent. value237.35M

Revenue2.19M

Net income-26.79M

Gross profit738K

Free cash flow-95.23M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out114.05M

Employees166

ListedMon, Dec 29, 2003

Free float61.97M

Float %83.4%

Short interest23.35M

Days to cover23.6d

Short volume65.2%

Squeeze score82 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.22 vs −$0.27

Last surprise+18.5% beat

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank9.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.42

Support2.78

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CATX

All disclosures →

No recent disclosed trades by Congress in CATX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CATX · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Lantheus Holdings, Inc. 10% owner · Common Stock · 2026-08-31	Sell	78.14K	$246K	2026-08-31	2026-09-02

SEC filings

EDGAR filings in CATX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.